Optic Nerve Data Helps Boost Diagnostic Performance Among Patients With MS
Investigators evaluated the added value of incorporating data on the optic nerve region to current diagnostic criteria for patients with multiple sclerosis.
Investigators evaluated the added value of incorporating data on the optic nerve region to current diagnostic criteria for patients with multiple sclerosis.
Study researchers found several clinical and imaging factors that predicted first-line treatment failure in patients with recently diagnosed relapsing remitting MS.
Researchers evaluated the viability and correlation of wearable biosensors with traditional clinical measures of disability in patients with MS.
Study researchers investigated the effects of cognitive reserve and brain reserve on social cognition in patients with Multiple Sclerosis.
Mixed results seen for effect of siponimod on cognitive processing speed in patients with secondary progressive multiple sclerosis
An electronic, unsupervised, patient-reported EDSS to assess disability in multiple sclerosis offers promise in clinical research and care for this population.
Study researchers investigated whether neurovascular contact with morphological changes influences the etiology of trigeminal neuralgia secondary to MS.
The approval was based on data from the phase 3b ENSEMBLE PLUS study that compared the frequency and severity of infusion-related reactions for a 2-hour Ocrevus infusion time to the previously approved 3.5-hour infusion time in patients with relapsing-remitting MS.
Reducing depressive symptoms early may result in better improvements in fatigue and pain interference in patients with multiple sclerosis.
People with chronic pain and multiple sclerosis often describe their pain as a combination of nociceptive, nociplastic, and/or neuropathic pain characteristics.